Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 21.10 Billion | USD 40.74 Billion | 6.8% | 2024 |
FrequentlyAsked Questions
The global hospital-acquired infection control market is expected to grow due to increasing awareness of HAIs, strict regulatory guidelines, and demand for sterilization and disinfection products.
According to a study, the global hospital-acquired infection control market size was worth around USD 21.10 Billion in 2024 and is expected to reach USD 40.74 Billion by 2034.
The global hospital-acquired infection control market is expected to grow at a CAGR of 6.8% during the forecast period.
North America is expected to dominate the hospital-acquired infection control market over the forecast period.
Leading players in the global hospital-acquired infection control market include Olympus Corporation, Cantel Medical, Getinge AB, STERIS plc, Belimed, STEELCO S.p.A., ASP, BD, Crosstex International Inc., Diversey Inc., MMM Group, 3M, bioMérieux SA, Sterigenics U.S. LLC, Cepheid, Dentsply Sirona, Mindray Bio-Medical Electronics Co., Ltd, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nova Biomedical, Sysmex Corporation, among others.
The report explores crucial aspects of the hospital-acquired infection control market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed